DENTSPLY SIRONA Q3 EPS Estimate Reduced by William Blair

Key Points

• The earnings estimates for DENTSPLY SIRONA's Q3 2025 have been cut by William Blair, now forecasting $0.47 per share, down from a previous estimate of $0.49.
• Multiple analysts have downgraded their ratings and price targets for DENTSPLY SIRONA, with a current consensus rating of "Hold" and an average target price of $18.64.
• DENTSPLY SIRONA declared a quarterly dividend of $0.16, effective October 10th, which results in an annual yield of 4.9%.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) - Analysts at William Blair dropped their Q3 2025 earnings estimates for DENTSPLY SIRONA in a report released on Thursday, August 7th. William Blair analyst B. Vazquez now anticipates that the medical instruments supplier will earn $0.47 per share for the quarter, down from their prior forecast of $0.49. The consensus estimate for DENTSPLY SIRONA's current full-year earnings is $1.84 per share. William Blair also issued estimates for DENTSPLY SIRONA's Q4 2025 earnings at $0.46 EPS, FY2025 earnings at $1.88 EPS, Q1 2026 earnings at $0.46 EPS, Q2 2026 earnings at $0.55 EPS, Q3 2026 earnings at $0.50 EPS and FY2026 earnings at $2.01 EPS.

XRAY has been the subject of a number of other reports. Barrington Research set a $18.00 price target on shares of DENTSPLY SIRONA and gave the company an "outperform" rating in a research report on Friday, August 8th. Morgan Stanley cut shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price target for the company. in a research report on Tuesday, April 15th. UBS Group dropped their price target on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a research report on Friday, August 8th. Wall Street Zen cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Saturday. Finally, Stifel Nicolaus dropped their price target on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating for the company in a research report on Friday, August 8th. Twelve research analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $18.64.

DENTSPLY SIRONA Trading Up 5.2%

XRAY stock traded up $0.68 during trading on Monday, reaching $13.73. 3,166,929 shares of the stock were exchanged, compared to its average volume of 2,997,092. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. The business has a 50 day moving average price of $15.59 and a 200-day moving average price of $15.81. DENTSPLY SIRONA has a 1 year low of $12.16 and a 1 year high of $27.48. The firm has a market capitalization of $2.74 billion, a price-to-earnings ratio of -2.90, a P/E/G ratio of 0.78 and a beta of 0.94.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.02. The business had revenue of $936.00 million for the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The company's revenue was down 4.9% compared to the same quarter last year. During the same period last year, the firm posted $0.49 earnings per share.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of hedge funds have recently added to or reduced their stakes in the business. Arrowstreet Capital Limited Partnership lifted its stake in DENTSPLY SIRONA by 0.5% in the second quarter. Arrowstreet Capital Limited Partnership now owns 899,802 shares of the medical instruments supplier's stock valued at $14,289,000 after buying an additional 4,899 shares during the last quarter. M&T Bank Corp lifted its stake in DENTSPLY SIRONA by 159.9% in the second quarter. M&T Bank Corp now owns 26,738 shares of the medical instruments supplier's stock valued at $424,000 after buying an additional 16,450 shares during the last quarter. Brandes Investment Partners LP lifted its stake in DENTSPLY SIRONA by 257.2% in the second quarter. Brandes Investment Partners LP now owns 376,662 shares of the medical instruments supplier's stock valued at $5,981,000 after buying an additional 271,221 shares during the last quarter. Edgestream Partners L.P. bought a new stake in DENTSPLY SIRONA in the second quarter valued at $659,000. Finally, Norges Bank bought a new stake in DENTSPLY SIRONA in the second quarter valued at $39,700,000. Institutional investors and hedge funds own 95.70% of the company's stock.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 4.7%. The ex-dividend date of this dividend is Friday, September 26th. DENTSPLY SIRONA's payout ratio is currently -13.50%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.